I wouldn’t mind hearing from @Gumnut70 to give his current thoughts on DEP-Dudetaxel and the wider DEP program.
It was my contention for years that DEP-Dudetaxel was going nowhere, was likely to be a dud and would never commercialised. Gumnut70 however said I was completely clueless on the topic on a number of occasions, and he diligently and in detail explained to the forum why DEP-Dudetaxel was going to be a blockbuster and would revolutionise cancer treatment around the world. Cue a thunderous amount of thumbs up and insight bulbs.
However, subsequent to the recent underwhelming Phase 2 results (which were 5 years late), Starpharma in their webinar update have announced that DEP-Dudetaxel is being de-prioritised.
Just wondering @Gumnut70 (and others), what are your recalibrated thoughts are on the DEP program going forward.
- Forums
- ASX - By Stock
- SPL
- DEP-DUDetaxel
DEP-DUDetaxel
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.8¢ |
Change
0.002(2.08%) |
Mkt cap ! $40.41M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.8¢ | $2.321K | 23.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 9000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 0.097 |
2 | 106430 | 0.096 |
3 | 538090 | 0.095 |
1 | 5000 | 0.094 |
1 | 28393 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 9000 | 2 |
0.105 | 96531 | 4 |
0.110 | 39609 | 6 |
0.115 | 138531 | 6 |
0.120 | 89055 | 5 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |